Hims & Hers Health Change in Accounts Receivable 2020-2025 | HIMS

Hims & Hers Health annual/quarterly change in accounts receivable history and growth rate from 2020 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
  • Hims & Hers Health change in accounts receivable for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
  • Hims & Hers Health change in accounts receivable for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
  • Hims & Hers Health annual change in accounts receivable for 2024 was $0B, a 0% decline from 2023.
  • Hims & Hers Health annual change in accounts receivable for 2023 was $0B, a 0% decline from 2022.
  • Hims & Hers Health annual change in accounts receivable for 2022 was $0B, a 0% decline from 2021.
Hims & Hers Health Annual Change in Accounts Receivable
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $N/A
2018 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $9.717B $1.477B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.602B 59.29
Tempus AI (TEM) United States $13.186B 0.00
Doximity (DOCS) United States $12.437B 55.33
IRhythm Technologies (IRTC) United States $5.323B 0.00
Hinge Health (HNGE) United States $4.319B 0.00
Inspire Medical Systems (INSP) United States $2.748B 40.40
Privia Health (PRVA) United States $2.626B 194.54
Heartflow (HTFL) $2.422B 0.00
Phreesia (PHR) United States $1.808B 0.00
Enovis (ENOV) United States $1.771B 9.36
10x Genomics (TXG) United States $1.752B 0.00
Omnicell (OMCL) United States $1.520B 29.28
Schrodinger (SDGR) United States $1.438B 0.00
Azenta (AZTA) United States $1.410B 61.52
Clover Health Investments (CLOV) United States $1.356B 0.00
Claritev (CTEV) United States $1.180B 0.00
Evolent Health (EVH) United States $1.140B 0.00
Fulgent Genetics (FLGT) United States $0.659B 0.00
Zepp Health (ZEPP) Netherlands $0.570B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.474B 0.00
Talkspace (TALK) United States $0.445B 132.75
Butterfly Network (BFLY) United States $0.390B 0.00
Carlsmed (CARL) United States $0.380B 0.00
TruBridge (TBRG) United States $0.298B 52.29
Outset Medical (OM) United States $0.244B 0.00
Health Catalyst (HCAT) United States $0.235B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
Nyxoah SA (NYXH) Belgium $0.220B 0.00
KORU Medical Systems (KRMD) United States $0.194B 0.00
CapsoVision (CV) United States $0.187B 0.00
MDxHealth SA (MDXH) Belgium $0.167B 0.00
CareCloud (CCLD) United States $0.135B 6.12
ImmunoPrecise Antibodies (IPA) Canada $0.127B 0.00
American Well (AMWL) United States $0.113B 0.00
EUDA Health Holdings (EUDA) Singapore $0.099B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.071B 0.00
Pulmonx (LUNG) United States $0.068B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Precipio (PRPO) United States $0.023B 0.00
PROFUSA (PFSA) United States $0.016B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.005B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00